Emma Guttman
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Emma Guttman sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Emma Guttman: 4 sponsored US clinical trials, 1 recruiting.
Emma Guttman sponsors 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alopecia Areata, with 1 trials.
Upper-quartile sponsor footprint
Emma Guttman sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
Regeneron AA Multicenter (Dupilumab)
NCT05551793
Ritlecitinib for Cicatricial Alopecia
NCT05549934
Dual JAK1/TYK2 Inhibitor for Cicatricial Alopecia
NCT05076006
A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata
NCT02684097
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 4 |
Therapeutic Areas
What is open in the Emma Guttman pipeline
1 recruiting of 4 indexed (25% open); 3 completed (75%).
Phase mix: 0 late (III/IV) vs 4 early (I/II) (early-phase heavy).
Top condition: Alopecia Areata (1 trial), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Emma Guttman: open-pipeline peers nationwide
Peers matched on 4 registered trials and 25% open enrollment, not the therapeutic-area sidebar.
Emma Guttman sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 trials (± recruiting share)
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors near 25% open enrollment (± trial volume)
- AB Science · 25% recruiting · 8 trials
- Abbott Point of Care · 25% recruiting · 8 trials
- Accutar Biotechnology · 25% recruiting · 4 trials
- Adrienne G. Waks · 25% recruiting · 4 trials
Related
What to do with this Emma Guttman page
4 registered trials is a research-attention snapshot, not an endorsement of Emma Guttman or any single study.
- 1 of Emma Guttman's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Alopecia Areata is the condition Emma Guttman studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alopecia Areata trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Emma Guttman pipeline card: 4 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.